PCOS (Polycystic Ovary Syndrome)
PCOS (Polycystic Ovary Syndrome) is the most common endocrine disorder in reproductive-age women, affecting approximately 10-13% of this population worldwide.1 Diagnosis requires two of three Rotterdam criteria: ovulatory dysfunction (irregular or absent cycles), hyperandrogenism (clinical signs such as hirsutism or acne, or biochemical elevation of androgens), and polycystic ovarian morphology on ultrasound.2 Insulin resistance is present in many women with PCOS, including a substantial proportion at a normal BMI, and in these women it drives androgen overproduction, follicular arrest, and anovulation.34 PCOS is heterogeneous, but where this metabolic dysfunction is present it represents a modifiable metabolic driver rather than an immutable condition.5
PCOS is one of the most common causes of ovulatory infertility.6 When ovulation does not occur reliably, conception becomes difficult for couples trying to conceive. The ovulatory disruption follows directly from the insulin and androgen dysfunction at the core of the condition.7 Restoring ovulation means correcting that dysfunction rather than forcing an isolated ovulatory event.8
A common question is whether Clomid (clomiphene citrate) addresses PCOS infertility. Clomid can induce ovulation by blocking estrogen receptors in the hypothalamus and pituitary, reducing estrogen-mediated negative feedback and prompting increased release of FSH and LH.9 Clomid can produce a cycle for some women with PCOS.10 As a selective estrogen receptor modulator, Clomid acts only as an ovulation stimulus. It does not correct the insulin resistance that drives PCOS, so the metabolic dysfunction persists between cycles even when ovulation is achieved.
In NaProTechnology and restorative reproductive medicine practice, PCOS is approached with the goal of identifying and correcting what disrupted the ovulatory cycle.8 Lifestyle modification and dietary changes to address insulin resistance form the foundation: for many patients, even a modest reduction in body weight can help restore ovulation.5 Insulin sensitization with agents such as metformin or myo-inositol, cycle charting and ovulation monitoring to confirm when and whether ovulation is actually occurring, and targeted hormonal support address the underlying physiology.811 Restorative care works to re-establish the patient's own ovulatory cycle, addressing the underlying disruption directly.12
Both partners warrant evaluation. In a large multicentre survey of infertile couples, disorders were identified in both partners in 39% of cases, and ovulation disorders were the leading female cause; these findings indicate that male factor frequently co-exists with female infertility, including in couples where ovulatory dysfunction is present.13 PCOS-related anovulation should be assessed alongside semen parameters, rather than in isolation.14
Cited in this entry
- Polycystic Ovarian Syndrome. https://www.ncbi.nlm.nih.gov/books/NBK459251/
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). https://pubmed.ncbi.nlm.nih.gov/14688154/
- Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Human reproduction (Oxford, England). 2013. https://pubmed.ncbi.nlm.nih.gov/23315061/
- Diamanti-Kandarakis E, Dunaif A Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine reviews. 2012. https://pubmed.ncbi.nlm.nih.gov/23065822/
- Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ Lifestyle changes in women with polycystic ovary syndrome. The Cochrane database of systematic reviews. 2019. https://pubmed.ncbi.nlm.nih.gov/30921477/
- Balen AH Ovulation induction in the management of anovulatory polycystic ovary syndrome. Molecular and cellular endocrinology. 2013. https://pubmed.ncbi.nlm.nih.gov/23084977/
- Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clinica chimica acta; international journal of clinical chemistry. 2020. https://pubmed.ncbi.nlm.nih.gov/31733195/
- Hilgers TW. Chapter 45: Amenorrhea and Anovulation. The Medical and Surgical Practice of N. https://rrmacademy.org/library/chapter-45-amenorrhea-and-anovulation/
- Tadesse TM Clomiphene citrate in the management of anovulation: a review of mechanisms, outcomes, and clinical challenges. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2026. https://pubmed.ncbi.nlm.nih.gov/41863134/
- Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. The New England journal of medicine. 2007. https://pubmed.ncbi.nlm.nih.gov/17287476/
- Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. The New England journal of medicine. 1998. https://pubmed.ncbi.nlm.nih.gov/9637806/
- Kicinska AM, et al. Successful Implementation of Menstrual Cycle Biomarkers in the Treatment of Infertility in Polycystic Ovary Syndrome-Case Report. Healthcare (Basel). 2023;11(4). https://pubmed.ncbi.nlm.nih.gov/36833150/
- Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J et al. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Human reproduction (Oxford, England). 1991. https://pubmed.ncbi.nlm.nih.gov/1757519/
- Aschauer J, Ott J, Selzer C, Ghobrial S, Fitz V, Hager M The prevalence of abnormal semen parameters in male partners of women with anovulatory polycystic ovarian syndrome: a retrospective case-control study. Archives of gynecology and obstetrics. 2025. https://pubmed.ncbi.nlm.nih.gov/39365473/
Authoritative References
How other clinical authorities define this term. RRM Academy curates these verbatim or under fair use so the medical consensus is visible alongside our RRM-contextualized definition above.
- MeSH D011085
A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
- NCI Thesaurus
A disorder that manifests as multiple cysts on the ovaries. It results in hormonal imbalances and leads to irregular and abnormal menstrual periods, excess growth of hair, acne eruptions and obesity.
- MedlinePlus
Polycystic ovary syndrome (PCOS) is the name for set of symptoms that are related to an imbalance of hormones. PCOS affects the ovaries, as well as many other parts of the body.
- Wikipedia Polyendocrine_metabolic_ovarian_syndrome
Polyendocrine metabolic ovarian syndrome (PMOS), previously called polycystic ovary syndrome (PCOS), is the most common hormonal disorder in women of reproductive age.
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.